Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
M Kuoppamäki, E Syvälahti, J Hietala
Index: Eur. J. Pharmacol. 245 , 179-182, (1993)
Full Text: HTML
Abstract
The effects of the atypical antipsychotic drug, clozapine, and its two major metabolites in man, N-desmethylclozapine and clozapine N-oxide, on 5-HT1C receptor mediated phosphoinositide hydrolysis were studied in rat choroid plexus. Clozapine and N-desmethylclozapine antagonized 5-HT-stimulated phosphoinositide hydrolysis with IC50 values of 110 and 29.4 nM, respectively. Clozapine N-oxide was less potent. None of the compounds stimulated phosphoinositide hydrolysis per se. The Ki values for [3H]mesulergine displacement in choroid plexus were in accordance with phosphoinositide hydrolysis data. In conclusion, this study demonstrates that clozapine and one of its major metabolites in man, N-desmethylclozapine, are potent 5-HT1C receptor antagonists. These properties of clozapine and N-desmethylclozapine should be considered when the atypical effects of clozapine are evaluated in vivo.
Related Compounds
Related Articles:
2015-01-01
[J. Pharmacol. Toxicol. Methods 76 , 83-95, (2015)]
2015-06-15
[Biochem. Pharmacol. 95 , 311-23, (2015)]
2015-06-01
[J. Am. Soc. Mass Spectrom. 26 , 967-73, (2015)]
2014-11-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 970 , 1-7, (2014)]
2015-02-01
[Behav. Brain Res. 278 , 186-92, (2015)]